Edgestream Partners, L.P.

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1535061 Princeton, NJ

Position in ARWR

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$5,768,211

+$3,346,238 QoQ

Shares Held

91,997

+152.2% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Edgestream Partners, L.P. holds $88,282,973 across 25 Biotechnology names. ARWR ranks #4 (6.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	157,472	$14,821,264
2	EXEL	Exelixis, Inc.	174,455	$7,482,374
3	RVMD	Revolution Medicines, Inc.	69,262	$6,735,729
4	ARWR	Arrowhead Pharmaceuticals, Inc. This page	91,997	$5,768,211
5	TGTX	Tg Therapeutics, Inc.	168,351	$5,592,620
6	IONS	Ionis Pharmaceuticals Inc	68,369	$5,133,828
7	AGIO	Agios Pharmaceuticals, Inc.	143,731	$4,862,419
8	ACAD	Acadia Pharmaceuticals Inc	191,328	$4,258,961

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,768,211	91,997	+152.2%	Shares	Sole	2026-05-18
2025-12-31	$2,421,973	36,481	+18.4%	Shares	Sole	2026-02-13
2025-06-30	$486,703	30,804	-89.9%	Shares	Sole	2025-08-13
2025-03-31	$3,892,159	305,507	+153.7%	Shares	Sole	2025-05-02
2024-12-31	$2,263,726	120,411	+123.3%	Shares	Sole	2025-02-07
2024-06-30	$1,401,328	53,918	+8.9%	Shares	Sole	2024-08-09
2023-12-31	$1,514,363	49,489	+19.9%	Shares	Sole	2024-02-14
2023-09-30	$1,109,381	41,287	—	Shares	Sole	2023-11-15
No filing history on record for this holder in this stock.